Bacterial resistance to conventional antibiotics is a major challenge in controlling infectious diseases and has necessitated the development of novel approaches in antimicrobial therapy. One such approach is the use of antimicrobial peptides, such as the bacterially produced bacteriocins. Carnocyclin A (CclA) is a 60-amino acid circular bacteriocin produced by Carnobacterium maltaromaticum UAL307 that exhibits potent activity against many Gram-positive bacteria. Lipid bilayer and single channel recording techniques were applied to study the molecular mechanisms by which CclA interacts with the lipid membrane and exerts its antimicrobial effects. Here we show that CclA can form ion channels with a conductance of 35 pS in 150 mM NaCl solution. This channel displays a linear current-voltage relationship, is anion-selective, and its activation is strongly voltage-dependent. The formation of ion channels by CclA is driven by the presence of a negative membrane potential and may result in dissipation of membrane potential. Carnocyclin A's unique functional activities as well as its circular structure make it a potential candidate for developing novel antimicrobial drugs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbamem.2009.05.008DOI Listing

Publication Analysis

Top Keywords

circular bacteriocin
8
ion channels
8
membrane potential
8
bacteriocin carnocyclin
4
carnocyclin forms
4
forms anion-selective
4
anion-selective channels
4
channels lipid
4
lipid bilayers
4
bilayers bacterial
4

Similar Publications

The antimicrobial peptide (AMP) circularized bacteriocin enterocin AS-48 produced by sp. exhibits broad-spectrum antibacterial activity via dimer insertion into the plasma membrane to form membrane pore structures, compromising membrane integrity and leading to bactericidal activity. A specific alpha-helical region of enterocin AS-48 has been shown to be responsible for the membrane-penetrating activity of the peptide.

View Article and Find Full Text PDF

Unlabelled: APC 4099, isolated from bees' gut, has been identified as a promising candidate for food biopreservation. Antimicrobial activity screening revealed a broad-spectrum inhibition potential, ranging from gram-positive pathogenic bacteria to fungi responsible for food spoilage. Genomic analysis identified biosynthetic gene clusters coding for several antimicrobial peptides and secondary metabolites.

View Article and Find Full Text PDF

Identification and characterization of a circular bacteriocin, garvicin SC, a novel garvicin ML variant, produced by Lactococcus garvieae ABG0038.

J Biosci Bioeng

November 2024

Bioscience Research Laboratory, Sumitomo Chemical Co., Ltd., 1-98 Kasugadenaka 3-chome, Konohana-ku, Osaka 554-8558, Japan.

We have identified and characterized a circular bacteriocin, termed garvicin SC (GarSC), produced by Lactococcus garvieae ABG0038 isolated from pine cones. Genome analysis of L. garvieae ABG0038 revealed that GarSC was a variant of the circular bacteriocin, garvicin ML (GarML), caused by an amino acid substitution, and predicted that GarSC was produced through a biosynthetic mechanism very similar to that of GarML.

View Article and Find Full Text PDF

Genomic Insights into ENM104: A Probiotic with Potential Antimicrobial and Cholesterol-Reducing Properties.

Antibiotics (Basel)

August 2024

Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand.

Article Synopsis
  • The study focuses on the strain ENM104, known for its potential probiotic effects, including lowering cholesterol and producing GABA, a beneficial neurotransmitter.
  • ENM104's genomic analysis revealed a circular chromosome and plasmid with genes related to probiotic traits, stress adaptation, bile tolerance, vitamin biosynthesis, and antimicrobial properties.
  • Results showed ENM104's ability to inhibit pathogenic bacteria, suggesting its promising applications in pharmaceuticals and food industries, with recommendations for further clinical research.
View Article and Find Full Text PDF

Introduction: Antimicrobial-resistant pathogens present an ongoing threat to human and animal health, with deaths linked to antimicrobial resistance (AMR) predicted to increase annually. While the misuse and overuse of antibiotics in humans undoubtedly contribute to this escalation, antibiotic use in the veterinary field, including companion animals, also plays a contributing role. Pet owners' desire to improve the quality of life of their pets is likely to support antibiotic use in this field.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!